Unique collaboration between research and business culminates at Aarhus Investor Summit

Aarhus Investor Summit | Science Edition is an annual event that works to give startups and spinouts the opportunity to meet and attract local, national and international capital. In a unique collaboration with Aarhus University's Technology Transfer Office (TTO), this year's first summit gives the stage to important research from Aarhus University.

"Investing in knowledge-intensive spinouts and research is a very special discipline. At the Aarhus Investor Summit Science Edition, ten spinout cases from Aarhus University will have a strong platform to pitch their research to a wide audience of investors - and the investors can network and learn from each other. Hopefully, this will provide a breeding ground for future collaborations and investments and create even more knowledge-intensive companies in Aarhus," says Mai Louise Agerskov, CEO of INCUBA.

"The researchers and their projects will hopefully gain relationships with both national and international investors as well as personal contacts that can lead to knowledge, but also capital and investments in their companies. Our collaboration with Aarhus Investor Summit shows that we have strong research that can give rise to companies, but also that there is a great interest from investors who want to help bring the research into the business community and transform it into companies," adds Anette Poulsen Miltoft, Head of Function at AU Technology Transfer Office.

Knowledge-intensive spinouts on Investors' radar

With three biotech companies on his CV and more than DKK 700 million raised in capital, Simon Glerup is a perfect example of a researcher from Aarhus University whom investors can meet at the Aarhus Investor Summit. As co-founder of Draupnir Bio, Muna Therapeutics and Teitur Trophics, he has raised more than DKK 700 million in the last three years, and at the Aarhus Investor Summit, he will share some of the most important lessons he and his partners have learned in this intersection of science and business.

"I believe it is important to attend the Aarhus Investor Summit for three reasons. First, it is important to support and strengthen the local investor ecosystem. Secondly, it is essential that we meet and talk about how we can amplify the trend of the growing cluster of biotech companies in Aarhus. Last but not least, the Aarhus Investor Summit is an opportunity to meet capital. Not only in the form of investments but also intellectual and social capital," says Simon Glerup.